Imperial College London
Portrait Picture

ProfessorIainMcNeish

Faculty of Medicine, Department of Surgery & Cancer

Chair in Oncology
 
 
 
//

Contact

 

+44 (0)20 7594 2185i.mcneish Website

 
 
//

Assistant

 

Ms Sophie Lions +44 (0)20 7594 2792

 
//

Location

 

G036Institute of Reproductive and Developmental BiologyHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@inproceedings{Marth:2019,
author = {Marth, C and Vulsteke, C and Rubio, MJ and Makker, V and Braicu, EI and McNeish, IA and Radoslaw, M and Ayhan, A and Hasegawa, K and Wu, X and Dutta, L and Xu, C and Keefe, SM and Lee, J and Pignata, S},
publisher = {OXFORD UNIV PRESS},
title = {ENGOT-EN9/LEAP-001: A phase III, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer},
url = {https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000491295503112&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb},
year = {2019}
}
Download

RIS format (EndNote, RefMan)

TY  - CPAPER
AU  - Marth,C
AU  - Vulsteke,C
AU  - Rubio,MJ
AU  - Makker,V
AU  - Braicu,EI
AU  - McNeish,IA
AU  - Radoslaw,M
AU  - Ayhan,A
AU  - Hasegawa,K
AU  - Wu,X
AU  - Dutta,L
AU  - Xu,C
AU  - Keefe,SM
AU  - Lee,J
AU  - Pignata,S
PB  - OXFORD UNIV PRESS
PY  - 2019///
SN  - 0923-7534
TI  - ENGOT-EN9/LEAP-001: A phase III, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000491295503112&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
ER  -
Download